Latest filing published 11 Aug 2026 for Embecta Corp., €5,661. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
This profile gathers the share dealings of Jean Casner across 2 companies, led by Embecta Corp. and Cantel Medical Corp. The record holds 8 filings, for trades running from 2 June 2021 to 9 August 2026.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
The latest filing, published on 11 August 2026, reports a share grant of €5,661 in Embecta Corp. Filings reach the SEC (Form 4) feed a median of 3 days after the trade. US insiders must file a Form 4 within two business days of a trade. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
8 of 8 declarations